Peripheral Vascular Disease
Diabetes and Peripheral Vascular Disease (PVD) continue to be a growing epidemic globally, universally placing enormous economic toll on national healthcare systems. With new emerging medical technologies like MIMOSA Pro, however, there is the potential to diagnosis these conditions much earlier before the development of detrimental complications.Get A Demo
Diabetes and Peripheral Vascular Disease (PVD) continue to be a growing epidemic globally, universally placing enormous economic toll on national healthcare systems. With new emerging medical technologies however, there is the potential to diagnosis these conditions much earlier before the development of detrimental complications.
One of the biggest challenges within PVD management for healthcare systems is the subset of Peripheral Arterial Disease (PAD) patients and those individuals getting access to appropriate vascular assessments. One would hope that most, if not all, PAD patients would have at least an objective non-invasive vascular evaluation before primary amputation occurs, but this is simply not the case in many healthcare settings.
The increasing knowledge that the prognosis of Peripheral Arterial Disease (PAD) and Chronic Limb Ischemia (CLI) is closely correlated to the functional perfusion level of the affected extremity, rather than the macro-vascular structure, may provide better management of these vascular issues. For example, regional foot perfusion imaging may predict wound healing success in addition to becoming a dependable surveillance tool in the management of persons with diabetic foot disease. With this increasing interest and continued understanding of PAD/CLI, vascular surgery moves towards achieving a reduction in persistent ulceration and decreasing the rate of unnecessary amputations for this group of patients.
There are similar compromised vascular diseases where MIMOSA Pro assessment can make a huge difference. For example, MIMOSA Pro allows for early assessment and diagnosis for patients who have peripheral vascular disease PVD. The deoxyhemoglobin level has been shown to have a positive correlation to the severity of PVD.
So, this emerging assessment and diagnostic tool will have huge impact in the management of patients with compromised vasculature. MIMOSA Pro is going to change the way in which many of these patients are managed.
The tiny hand-held device can be used by nurses, doctors, or other clinicians, to collect & collate data for review by the expert clinician - allowing for greater efficiency & a reduction in workload for the clinician and unprecedented access to care for patients!Get a Demo